Accurate Prediction of Initial Busulfan Exposure Using a Test Dose With 2‐ and 6‐Hour Blood Sampling in Adult Patients Receiving a Twice‐Daily Intravenous Busulfan‐Based Conditioning Regimen-Reference-Cited by-同舟云学术

Accurate Prediction of Initial Busulfan Exposure Using a Test Dose With 2‐ and 6‐Hour Blood Sampling in Adult Patients Receiving a Twice‐Daily Intravenous Busulfan‐Based Conditioning Regimen

Published:2018-12-04 Issue:5 Volume:59 Page:638-645
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Huang Jingjing¹,Li Ziwei¹,Liang Wu²,Chen Bing¹,Hu Jiong³,Yang Wanhua¹

Affiliation:

1. Department of PharmacyRuijin HospitalShanghai Jiaotong University School of Medicine Shanghai China

2. NeoTrident Co. Ltd. Beijing China

3. Department of Blood Marrow TransplantationRuijin Hospital Shanghai Jiaotong University School of Medicine Shanghai China

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.1354

Reference40 articles.

1. Busulfan in Hematopoietic Stem Cell Transplantation

2. Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantation

3. Busulfan systemic exposure relative to regimen-related toxicity and acute graft-versus-host disease: Defining a therapeutic window for i.v. BuCy2 in chronic myelogenous leukemia

4. Association between busulfan exposure and outcome in children receiving intravenous busulfan before hematopoietic stem cell transplantation;Ansari M;Ther Drug Monit,2014

5. Targeted Busulfan therapy with a steady-state concentration of 600–700 ng/mL in patients with sickle cell disease receiving HLA-identical sibling bone marrow transplant

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population Pharmacokinetic Model of Intravenous Busulfan in Hematopoietic Cell Transplantation: Systematic Review and Comparative Simulations;Clinical Pharmacokinetics;2023-07

2. External Evaluation of Population Pharmacokinetic Models of Busulfan in Chinese Adult Hematopoietic Stem Cell Transplantation Recipients;Frontiers in Pharmacology;2022-07-07

3. The Correlation Between Busulfan Exposure and Clinical Outcomes in Chinese Pediatric Patients: A Population Pharmacokinetic Study;Frontiers in Pharmacology;2022-06-16

4. NRF2 -617 C/A Polymorphism Impacts Proinflammatory Cytokine Levels, Survival, and Transplant-Related Mortality After Hematopoietic Stem Cell Transplantation in Adult Patients Receiving Busulfan-Based Conditioning Regimens;Frontiers in Pharmacology;2020-12-15

5. Limited Sampling Strategies Supporting Individualized Dose Adjustment of Intravenous Busulfan in Children and Young Adults;Therapeutic Drug Monitoring;2020-06